Switzerland

Mon
24
Feb

Switzerland Unofficially Launches Cannabis Pilot, What’s Next?

Unlike France’s upcoming cannabis trial, Switzerland will be pursuing an altogether more ambitious project. Though the Swiss government would monitor a larger number of users, the pilot will test the viability of legalising recreational cannabis in Switzerland.

Related: How Germany’s Hemp Association Fights Cannabis Criminalisation

Indeed, the stakes are much higher — but, if successful, Europe could expect an immediate regulatory windfall.

Wed
29
Jan

Davos cannabis conclave advances cause for legalisation

The second annual, premier cannabis industry event – the Cannabis Conclave – returned to Davos this January to bring together industry leaders and policy makers.

This year the Cannabis Conclave brought together cannabis industry executives, global investors, policy makers and international media to fuel the legalisation debate globally, both for recreational and medical cannabis, and to highlight the growing legitimacy and maturity of the legal cannabis industry.

Fri
24
Jan

Swiss cannabis market worth up to half a billion francs annually

Cannabis remains by far the most widespread drug enjoyed in Switzerland, even if the value of the market is much lower than that for cocaine, researchers have found.

A study publishedexternal link Thursday by several groups including Addiction Switzerland estimates the national cannabis market to be worth up to CHF500 million ($516 million).

But in canton Vaud, where the study was carried out, the figures show that the total market value was around half that of for cocaine – a finding that Frank Zobel, co-director of Addiction Switzerland, said was a surprise.

Wed
22
Jan

Cannabis House at Davos 2020 to tackle climate change, sustainability, healthcare

In a show of the growing acceptance of the pot industry, the World Economic Forum in Davos will host the Cannabis House for the second year in a row this week.

Top cannabis industry executives will flock to the small Swiss town for a two-day conference at the Cannabis House hosted by CannTech.

Discussions will aim to highlight “the economic role of cannabis in the future of healthcare, international trade, investment, and environmental and resource security, with the goal of creating a fair and viable cannabis-related industry globally.”

Tue
21
Jan

Pot industry heads to Davos as stocks rebound

Tough times in the cannabis industry aren’t stopping its leaders from going to Davos.

For the second year in a row, there will be a Cannabis House in Davos, Switzerland this week alongside the schmoozing and speeches of the World Economic Forum. The 2020 offering promises to be “a little more formal and more professional” than last year’s, according to Jason Paltrowitz, executive vice president of corporate services at OTC Markets Group, one of the sponsors of the Cannabis House.

Cannabis House will feature a two-day conference focused on the themes of Davos 2020, including sustainability, climate change, social equity and impact investing.

Wed
04
Sep

Can Medical Marijuana Help Aging parents with dementia?

For decades, marijuana, even for medical uses, was demonized or questioned.  When states like Colorado legalized it for recreational use, more studies began to determine provable efficacy for its use as a medicine. The Federal government still classifies marijuana the same way it classifies heroin: harmful and with no medical benefits. Now we can see that this is wrong. When states legalized marijuana, referred to as cannabis here, they had an interest in getting data to see what good it could do. Proving efficacy could increase medical marijuana sales, benefit people who might at least find some medical use, and overall would bring tax dollars into the state coffers.

Fri
30
Aug

Let’s talk about medicinal cannabis in Switzerland

In June 2019, the Federal Council has submitted a proposal suggesting that medicinal cannabis in Switzerland should be made legal.

Over recent years, Switzerland has “been relatively progressive on cannabis, including the legalisation of cannabis with no more than 1% THC.” For example, this level of legal THC percentage, although it has to be less than 1%, this is still considerably in more than other countries – medicinal cannabis in Switzerland differs as in most other European countries legal THC limit is 0.2%.

Thu
22
Aug

4 continents, 1 deal: The global CBD export market is already here

On Aug. 19, the Colombian company PharmaCielo, which claims to be the country’s premier producer of medical-grade cannabis oil, announced that it had officially exported the first batch of CBD from Colombia to Switzerland. The actual deal to make the first commercial export of CBD to Europe happen was organized by PharmaCielo’s Canadian parent company of the same name.

Tue
20
Aug

Colombia begins shipping CBD to Switzerland

A Colombian cannabis producer has completed the country’s first commercial export of CBD isolate to Europe after its shipment arrived safely in Switzerland.

The Colombian government granted its first CBD isolate export permit to PharmaCielo (TSXV: PCLO) last month, and the firm has moved quickly to begin supplying the lucrative European market. It has now shipped its first batch to the Swiss office of Creso Pharma, an Australian pharmaceutical company it is in the process of purchasing for AU$122 million.

David Attard, chief executive at PharmaCielo, said the inaugural shipment was “symbolic on many levels”.

Wed
26
Jun

Switzerland aims to legalize medical marijuana

The Swiss government aims to make it easier for patients to get medical marijuana, proposing on Wednesday to allow prescriptions for cannabis to treat people suffering from cancer or other serious conditions.

The proposal, separate from a Swiss government push to allow some cities to experiment with recreational marijuana, would replace the current system, in which those seeking medical cannabis must apply for an exception from the Federal Health Office to get what is otherwise an illegal drug.

Marijuana is sometimes used to help cancer patients manage chronic pain, to help boost their appetites, and to reduce spasticity associated with multiple sclerosis.

Pages

Subscribe to RSS - Switzerland